¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"VA"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
VAC ventriculoatrial conduction; vincristine, doxorubicin, and cyclophosphamide; virus capsid antigen
vac vacuum
VAcc visual acuity with correction
vacc vaccination
VACO Veterans Affairs Central Office
VACTERL vertebral abnormalities, anal atresia, cardiac abnormalities, tracheoesophageal fistula and/or esophageal atresia, renal agenesis and dysplasia, and limb defects [association]
VAD venous access device; ventricular assist device; vinblastine and dexamethasone; vitamin A deficiency; virus-adjusting diluent
VAE venous air emboli
VAF viral-free antigen
VAG vibroarthrography
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
VA Virus-associated
VA Visual acuity
VA Vitamin A
VA volatile anesthetic
VA ventral anterior
VA ventriculo-arterial
VA vertebral arteries
VA vestibular aqueduct
VA villous atrophy
VA voltage
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • JrId: 7948
    JournalTitle: Virginia medical monthly.
    MedAbbr: Va Med Mon (1918)
    ISSN: 0042-6644
    ESSN:
    IsoAbbr:
    NlmId: 407231
  • JrId: 7949
    JournalTitle: Virginia nurse.
    MedAbbr: Va Nurse
    ISSN: 0270-7780
    ESSN:
    IsoAbbr:
    NlmId: 8005511
  • JrId: 7950
    JournalTitle: Virginia nurse quarterly.
    MedAbbr: Va Nurse Q
    ISSN: 0042-6695
    ESSN:
    IsoAbbr:
    NlmId: 42334
  • JrId: 7951
    JournalTitle: Il Valsalva.
    MedAbbr: Valsalva
    ISSN: 0042-2371
    ESSN:
    IsoAbbr:
    NlmId: 417400
  • JrId: 7952
    JournalTitle: Vardfacket.
    MedAbbr: Vardfacket
    ISSN: 0347-0911
    ESSN:
    IsoAbbr:
    NlmId: 7708473
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • N81.5
    Vaginal enterocele
    Áú Å»Àå
  • N94.2
    Vaginismus
    Áú°æ·Ã
  • N77.1*
    Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere
    ´Þ¸® ºÐ·ùµÈ °¨¿°¼º ¹× ±â»ýÃæ¼º Áúȯ¿¡¼­ÀÇ Áú¿°, ¿ÜÀ½¿° ¶Ç´Â ¿ÜÀ½Áú¿°
  • M21.0
    Valgus deformity, NEC
    ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ¿Ü¹Ý º¯Çü
  • C10.0
    Vallecula
    Èĵΰ³°î
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® vaginoplasty ÇÑ±Û Áú¼ºÇü¼ú
¼³¸í   
  ÁúÀÇ ¼ºÇü¿Ü°ú ¼ö¼ú.
¿µ¹® vagus nerve ÇÑ±Û ¹ÌÁֽŰæ
¼³¸í   
  Á¦ 10³ú½Å°æ(³ú½Å°æÀº ³ú¿¡¼­ ±â½ÃÇÑ ¸»ÃʽŰæÀ¸·Î ¸ðµÎ 12°³°¡ ÀÖ´Ù)ÀÇ À̸§. ¿Ã¸®ºê¿Í ¾Æ·¡¼Ò³ú°¢(inferior cerebellopontine angle)»çÀÌ ¼û³ú ¿ÜÃø¿¡¼­ ³ª¿À´Â ¸¹Àº »Ñ¸®¼¶À¯·ÎºÎÅÍ ±â½ÃÇÏ¿© »óÈĵνŰæ, µÇµ¹ÀÌÈĵνŰæ, °æÁú¸·°¡Áö, ±Í¹ÙÄû°¡Áö, Àεΰ¡Áö, ½ÉÀå°¡Áö, ±â°üÁöÀÎÁö, À§°¡Áö, °£°¡Áö, º¹°­°¡Áö, ÄáÆÏ°¡Áö, ÀενŰæ¾ó±â(pharyngeal plexus), Æó½Å°æ¾ó±â(pulmonic plexus), ½Äµµ½Å°æ¾ó±â(esophageal plexus), Àü ¹× ÈÄ ¹ÌÁֽŰ氣(anterior & posterior vagal trunk)ÀÇ °¡Áö¸¦ ³½´Ù. ¹ÌÁֽŰæÀº ¸ñÁ¤¸Æ±¸¸Û(jugular foramen)À» ÅëÇØ ³»·Á°¡¼­ »óÇϽŰæÀý(superior & inferior ganglion)°ú ¿¬°áµÇ°í, ¸ñ ¹× °¡½¿¸¦ Áö³ª º¹ºÎ¿¡ µµ´ÞÇÑ´Ù. ±Í, Çô, ÀεÎ, Èĵο¡ °¨°¢¼ºÀ¸·Î, ÀεÎ, ÈĵΠ¹× ½Äµµ¿¡ ¿îµ¿¼ºÀ¸·Î, ±×¸®°í ÈäºÎ ¹× º¹ºÎÀÇ ±â°ü¿¡ ³»À屸½É¼ºÀ¸·Î ºÐÆ÷ÇÑ´Ù.
  
  ¹ÌÁֽŰæ
  
  
¿µ¹® valgus ÇÑ±Û ¿Ü¹Ý-, ¹Ù±ù±ÁÀº-
¼³¸í   
  ¹Ù±ùÂÊÀ¸·Î ±¸ºÎ·¯Áø. ½ÅüºÎºÐÀÇ °¢ÀÌ ½ÅüÀÇ Áß¾Ó¼±À¸·ÎºÎÅÍ ¶³¾îÁ® Àִ º¯ÇüÀ» ¸»ÇÑ´Ù.
¿µ¹® valium ÇÑ±Û ¹ß·ý
¼³¸í   
  DiazepamÁ¦Á¦ÀÇ »óǰ¸í. È¸»öºûÀ» ¶í ¹é»öºÎÅ͠Ȳ»ö¿¡ À̸£´Â °áÁ¤¼ºÀÇ ºÐ¸». Á¤½Å¾ÈÁ¤Á¦³ª °ñ°Ý±ÙÀÌ¿ÏÁ¦·Î ¾²ÀδÙ. ÁøÁ¤ÀÛ¿ë°ú ÇÔ²² ´ë°³ È£Èí¾ïÁ¦ÀÛ¿ëÀÌ ³ªÅ¸³ª, °ú·®º¹¿ë½Ã »ý¸íÀ¯Áö¿¡ ÁöÀåÀ» ÁÙ ¼ö ÀÖ´Ù.
¿µ¹® Valsalva maneuver ÇÑ±Û ¹ß»ì¹ÙÁ¶ÀÛ
¼³¸í   
  1. ¼º¹®À» ´Ý°í °­Á¦È£±â¸¦ Çϴ °ÍÀ¸·Î¼­, À̶§¿¡ Èä°­³»¾ÐÀÌ Áõ°¡ÇÏ¿© ½ÉÀåÀ¸·Î µ¹¾Æ°¡´Â Á¤¸ÆÀ¯ÀÔÀÌ ¹æÇصȴÙ. 2. ¹Ù±ùÄ౸¸Û°ú ÀÔÀ» ¸·°í °­Á¦È£±â¸¦ Çϴ °ÍÀ¸·Î¼­, ±ÍÀεΰü°ú °¡¿îµ¥±Í ³»¾ÐÀÌ Áõ°¡ÇÏ¿© °í¸·ÀÌ ¿Ü¹æÀ¸·Î ¿òÁ÷ÀδÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vacuolation
    °øÆ÷Çü¼º, °øÆ÷È­
  • vacuole
    °øÆ÷
  • vacuolization
    °øÆ÷Çü¼º, °øÆ÷È­
  • vacutainer tube
    Áø°øÃ¤Ç÷°ü, ¹èÅ¥Å×À̳ʰü
  • vacuum
    Áø°ø
  • vacuum casting
    Áø°øÁÖÁ¶
  • vacuum chamber
    Áø°ø½Ç
  • vacuum dehydration
    Áø°øÅ»¼ö, Áø°ø°ÇÁ¶
  • vacuum distillation
    Áø°øÁõ·ù
  • vacuum extraction
    ÈíÀԺи¸, Áø°øºÐ¸¸
  • vacuum headache
    Áø°øµÎÅë
  • vacuum investing
    Áø°ø¸Å¸ô
  • vacuum suction
    Áø°øÈíÀÎ
  • vacuum tube
    Áø°ø°ü
  • vagabond¡¯s leukoderma
    ºÎ¶ûÀÚ¹é»öÇǺÎÁõ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vaginal fornix
    ÁúõÀå
  • vaginal infection
    Áú°¨¿°
  • vaginal spotting
    Á¡»óÁúÃâÇ÷
  • vaginal tablet
    Áú¾Ë¾à, ÁúÁ¤
  • vaginal vault
    ÁúµÕ±ÙõÀå
  • vaginalitis
    °íȯÁý¸·¿°
  • vaginismus
    Áú°æ·Ã
  • vaginitis
    Áú¿°
  • vaginocele
    ÁúÅ»ÃâÁõ
  • vaginodynia
    ÁúÅëÁõ
  • vaginogram
    ÁúÁ¶¿µ»çÁø
  • vaginography
    ÁúÁ¶¿µ¼ú
  • vaginomycosis
    Áú°õÆÎÀÌÁõ, ÁúÁø±ÕÁõ
  • vaginoperineal
    Áú»ô-, ÁúȸÀ½-
  • vaginopexy
    (¢¡colpopexy) Áú°íÁ¤¼ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vaccinoid reaction
    ¹é½Å¸ð¾ç¹ÝÀÀ
  • vaccinola
    (¢¡generalized vaccinia) Àü½Å¿ìµÎ
  • vacuolar
    °øÆ÷-
  • vacuolar degeneration
    °øÆ÷º¯¼º
  • vacuolar myelopathy
    °øÆ÷ô¼öº´Áõ
  • vacuolation
    °øÆ÷Çü¼º
  • vacuole
    °øÆ÷
  • vacuolization
    (¢¡vacuolation) °øÆ÷Çü¼º
  • vacutainer tube
    Áø°øÃ¤Ç÷°ü, ¹èÅ¥Å×À̳ʰü
  • vacuum
    Áø°ø
  • vacuum casting
    Áø°øÁÖÁ¶
  • vacuum chamber
    Áø°ø½Ç
  • vacuum cooling
    Áø°ø³Ã°¢
  • vacuum dehydration
    Áø°øÅ»¼ö, Áø°ø°ÇÁ¶
  • vacuum distillation
    Áø°øÁõ·ù
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vaccine therapy
    ¹é½Å¿ä¹ý(¡­èþÛö).
  • vaccine therapy
    ¹é½Å¿ä¹ý(¡­èþÛö).
  • vaccine, attenuated
    ¾àµ¶[È­] ¹é½Å
  • vaccine, inactivated virus
    ºÒȰ¼ºÈ­ ¹ÙÀÌ·¯½º ¹é½Å
  • vaccine, killed
    »ç¸ê¹é½Å
  • vaccine, live
    »ý¹é½Å
  • vaccine, monovalent
    Àϰ¡ (ìéʤ) ¹é½Å
  • vaccine, polyvalent
    ´Ù°¡ (Òýʤ) ¹é½Å
  • vaccine, subunit
    ¾Æ´ÜÀ§ ¹é½Å
  • vaccinia bovis ³ª
    ¿ìµÎ¹é½Å.
  • vaccinia gangrenosum ³ª
    ±«Àú¼º ¹é½Ã´Ï¾Æ.
  • vaccinia necrosum
    ±«»ç¼º Á¾µÎÁõ.
  • vaccinia necrosum
    ³ª ±«»ç¼º Á¾µÎÁõ.
  • vaccinia necrosum ³ª
    ±«»ç¼º Á¾µÎÁõ.
  • vaccinia virus
    ¿ìµÎ¹ÙÀÌ·¯½º.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Vallate papillae
    ¼º°ûÀ¯µÎ
    [¿¾ ¿ë¾î] À¯°ûÀ¯µÎ
  • Vallecula
    ¼Ò³ú°è°î
    [¿¾ ¿ë¾î] ¼Ò³ú°î
  • Valve
    ÆÇ¸·
    [¿¾ ¿ë¾î] ÆÇ
  • Valve of conary sinus
    ½ÉÀåÁ¤¸Æµ¿±¼ÆÇ¸·
    [¿¾ ¿ë¾î] °ü»óÁ¤¸Æµ¿ÆÇ
  • Valve of coronary sinus
    ½ÉÀåÁ¤¸Æµ¿±¼ÆÇ¸·
    [¿¾ ¿ë¾î] °ü»óÁ¤¸ÆÆÇ
  • Valve of inferior vena cava
    ¾Æ·¡´ëÁ¤¸ÆÆÇ¸·
    [¿¾ ¿ë¾î] ÇÏ´ëÁ¤¸ÆÆÇ
  • Valve of oval foramen
    Ÿ¿ø±¸¸ÛÆÇ¸·
    [¿¾ ¿ë¾î] ³­¿ø°øÆÇ
  • Valve of pulmonary trunk
    ÇãÆÄµ¿¸ÆÆÇ¸·
    [¿¾ ¿ë¾î] Æóµ¿¸ÆÆÇ
  • Valve of sinus venosus
    Á¤¸Æµ¿±¼ÆÇ¸·
    [¿¾ ¿ë¾î] Á¤¸Æµ¿ÆÇ
  • Valve of truncus pulmonaris
    ÇãÆÄµ¿¸ÆÆÇ¸·
    [¿¾ ¿ë¾î] Æóµ¿¸ÆÆÇ
  • Valvular sinus
    ÆÇ¸·µ¿±¼
    [¿¾ ¿ë¾î] ÆÇµ¿
  • Variation
    º¯ÀÌ
    [¿¾ ¿ë¾î] º¯ÀÌ
  • Variations of form
    Çüź¯ÀÌ
    [¿¾ ¿ë¾î] Çüź¯ÀÌ
  • Variations of site
    À§Ä¡º¯ÀÌ
    [¿¾ ¿ë¾î] À§Ä¡ÀÌ»ó
  • Vas prominens
    À¶±âÇ÷°ü
    [¿¾ ¿ë¾î] À¶±â¸Æ°ü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
  • vascular d.
    Ç÷°üÁúȯ
    úìηî¡äô
  • vascular h.
    Ç÷°üµÎÅë
    úìηÔé÷Ô
  • vascular s.
    Ç÷°ü°è
    úìηͧ
  • vascular(vasogenic) e.
    Ç÷°üÅ¿ºÎÁ¾, Ç÷°ü±âÀμººÎÁ¾
    úìηÐñì×àõ Ý©ðþ
  • vascularity
    Ç÷°üºÐÆ÷Á¤µµ
    úìηÝÂøÖïïÓø
  • vascularization
    Ç÷°üÈ­
    úìηûù
  • vasculitis
    Ç÷°ü¿°
    úìηæú
  • vasoactive center
    Ç÷°üȰ¼ºÁßÃß
    úìηüÀàõñéõÒ
  • vasoconstriction
    Ç÷°ü¼öÃà
    úìηâ¥õê
  • vasodilatation
    Ç÷°üÈ®Àå
    úìηüªíå
  • vasogenic
    Ç÷°ü¼º
    úìηàõ
  • vasomotor
    Ç÷°ü¿îµ¿°è
    úìηê¡ÔÑͧ
  • vasomotor p.
    Ç÷°ü¿îµ¿½Å°æ¸¶ºñ
    úìηê¡ÔÑãêÌèØ¦Ýö
  • vasopressor
    Ç÷¾Ð»ó½ÂÁ¦
    úìäâß¾ã°ð¥
  • vasopressor r.
    Ç÷°ü¼öÃà¼ö¿ëü
    úìηâ¥õêáôé»ô÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • van der Waals compound
    ¹Ý µ§ ¹ß½º È­ÇÕ¹°(ûùùêÚª)
  • van der Waals distance
    ¹Ý µ§ ¹ß½º °Å¸®
  • van der waals forces
    ¹Ý µ§ ¹ß½º Èû
  • van der Waals interactions
    ¹Ý µ§ ¹ß½º »óÈ£ÀÛ¿ë (ßÓû»íÂéÄ)
  • van der Waals radius
    ¹Ý µ§ ¹ß½º Áö¸§
  • van der Waals repulsive force
    ¹Ý µ§ ¹ß½º ¹Ý¹ß·Â (ÚãÚüÕô)
  • van der Waals shell
    ¹Ý µ§ ¹ß½º ²®Áú
  • van der Waals surface
    ¹Ý µ§ ¹ß½º Ç¥¸é (øúØü)
  • van Slyke method
    ¹Ý ½½¶óÀÌÅ©¹ý(Ûö)
  • van't Hoff complex
    ¹ÝÆ® È£ÇÁ º¹ÇÕü (ÜÜùêô÷)
  • van't Hoff equation
    ¹ÝÆ® È£ÇÁ ¹æÁ¤½Ä (Û°ïïãÒ)
  • van't Hoff factor
    ¹ÝÆ® È£ÇÁ ÀÎÀÚ(ì×í­)
  • van't Hoff isobar
    ¹ÝÆ® È£ÇÁ µî¾Ð¼±(ÔõäâàÊ)
  • van't Hoff isochore
    ¹ÝÆ® È£ÇÁ µî¿ë¼±(Ôõé»àÊ)
  • van't Hoff limiting law
    ¹ÝÆ® È£ÇÁ Á¦ÇÑ ¹ýÄ¢(ð¤ùÚÛööÎ)
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vagovagal reflex
    ¹ÌÁֽŰæ¹Ý»ç
  • vallecula
    °è°î, °î, ¿Í
  • Valsalva's maneuver
    ¹ß»ì¹Ù¹ý
  • value
    °ª, °¡Ä¡
  • valve
    ÆÇ¸·, ÆÇ
  • valve cusp
    ÆÇ¸·Ã·ÆÇ, ÆÇ¸·Ã·
  • valve replacement
    ÀΰøÆÇġȯ
  • valvula vasorum
    ¸Æ°üÆÇ¸·, ¸Æ°üÆÇ
  • valvulae conniventes
    À±»óÁÖ¸§,À±»óÃߺ®
  • valvular
    ÆÇ¸·ÀÇ, ÆÇÀÇ
  • valvular cusps
    ÷ÆÇ
  • valvular disease
    ÆÇ¸·Áõ
  • valvular endocarditis
    ÆÇ¸·½É³»¸·¿°
  • valvular heart disease
    ÆÇ¸·¼º½ÉÁúȯ
  • valvular insufficiency
    ½ÉÆÇ¸·ºÎÀüÁõ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • vaccinization
    Á¾µÎÈ­, ¿ÏÀü Á¾µÎ¹ý
  • vaccinogenous
    ¹é½Å »ý»ê¼º
    ¹é½ÅÀ» ¸¸µå´Â.
  • vaccinoid reaction
    °¡µÎ¼º ¹ÝÀÀ
  • vaccinophobia
    Á¾µÎ °øÆ÷, Á¾µÎ°øÆ÷Áõ
  • vaccinotherapy
    ¹é½Å ¿ä¹ý
    ¹é½ÅÀ» Ä¡·á ¸ñÀûÀ¸·Î ÀÌ¿ëÇÏ´Â °Í.
  • vacuolar
    °øÆ÷ÀÇ, °øÆ÷¼ºÀÇ
    °øÆ÷ÀÇ Á¸Àç°¡ Ư¡ÀûÀÎ.
  • vacuolar myelopathy
    °øÆ÷¼º ô¼öº´Áõ
  • vacuolate
    °øÆ÷È­ÇÏ´Ù
    ÀÛÀº °£°Ý ȤÀº °øÆ÷¸¦ Çü¼ºÇÏ´Ù.
  • vacuolated virus
    °øÆ÷¼º ¹ÙÀÌ·¯½º
  • vacuole
    °øÆ÷, ¾×Æ÷, ¼ÒÆ÷
    ¼¼Æ÷ÀÇ ¿øÇüÁú ³»¿¡ Çü¼ºµÈ ÀÛÀº °£±ØÀ̳ª ¼ÒÆ÷.
  • vacuome
    Áß¼ºÀû °øÆ÷, ¹ÙÄí¿È
    ¼¼Æ÷ ³»¿¡ Áß¼ºÀ¸·Î ¿°»öµÇ´Â °øÆ÷°è.
  • vacuum
    Áø°ø
    Áø°ø, °ø±â ¶Ç´Â ´Ù¸¥ °¡½º¸¦ ¹èÃâÇÑ °ø°£, °ø±â ¶Ç´Â °¡½º°¡ ¾ø´Â °ø°£.
  • vacuum baking
    Áø°ø ¼Ò¼º
    µµÀç ¼Ò¼º¿¡´Â Áø°ø ¼Ò¼º°ú º¸Åë ¼Ò¼º¹ýÀÌ Àִµ¥ Áø°ø ¼Ò¼ºÀº furnace ³»ºÎ¸¦ Áø°ø ÆßÇÁ·Î °¨¾ÐÇϸ鼭 Áø°øÇÏ¿¡¼­ ¼Ò¼ºÇÏ´Â °ÍÀ¸·Î µµÀçÀÇ ³»ºÎ¿¡ ±âÆ÷°¡ »ý±âÁö ¾Ê°í °ß°íÇÏ¸ç ¾Æ¸§´Ù¿î µµÀ縦 Á¦ÀÛÇÒ ¼ö ÀÖ´Â ¼Ò¼º¹ýÀÌ´Ù.
  • vacuum casting
    Áø°ø ÁÖÁ¶
    Áø°ø »óÅ¿¡¼­ ±Ý¼ÓÀ» ÁÖÁ¶ÇÏ´Â °Í.
  • vacuum chamber
    Áø°ø½Ç
    Áø°ø »óÅÂÀÇ °¡¿­°­À» °¡¸®Å²´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
vaccination, dtap Like DPT, DTaP protects from diphtheria, pertussis (whooping cough) and tetanus. Dtap is the same as dtp, except that it contains only acellular pertussis vaccine which is thought to cause fewer of the minor reactions associated with immunization and is also probably less likely to cause the more severe reactions occasionally seen following pertussis vaccination. Dtap is currently recommended only for the shots given at 18 months and 4-6 years of age.
(12 Dec 1998)
vaccination, german measles See Vaccination, MMR.
(12 Dec 1998)
vaccination, haemophilus influenzae type b See vaccination, hib.
(12 Dec 1998)
vaccination, hepatitis a When immediate protection against hepatitis a (infectious hepatitis) is needed, immunoglobulins are used. Protection is effective only if given within 2 weeks of exposure and lasts but 2-4 months. Immunoglobulins can be used to protect household contacts of someone with acute viral hepatitis and travelers to regions with poor sanitation and high hepatitis a rates, when the traveler has to depart sooner than the vaccines can take effect (about 2 weeks). Travelers can receive the immunoglobulin and vaccine simultaneously and be protected immediately and for longer term. When immediate protection is not needed, hepatitis a vaccines are considered for individuals in high-risk settings, including frequent world travelers, sexually active individuals with multiple partners, homosexual men, individuals using illicit drugs, employees of daycare centres, and certain health care workers, and sewage workers. Two hepatitis a vaccines called havrix and vaqta are commercially available in the u.s. Both are highly effective and provide protection even after only one dose. Two doses are recommended for adults and 3 doses for children (under 18 years of age) to provide prolonged protection.
(12 Dec 1998)
vaccination, hepatitis b Hepatits B (hep B) vaccine gives prolonged protection, but 3 shots over a half year are usually required. In the u.s., all infants receive hep b vaccine. Two vaccines (engerix-b, and recombivax-hb) are available in the us. The first dose of hep b vaccine is frequently given while the newborn is in the hospital or at the first doctor visit following birth. The second dose is given about 30 days after the initial dose. A booster dose is performed approximately six months later. Babies born to mothers testing positive for hep b receive, in addition, hbig (hep b immune globulin) for prompt protection. Older children (11-12 years) are advised to receive a hep b booster as are adults in high-risk situations including healthcare workers, dentists, intimate and household contacts of patients with chronic hep b infection, male homosexuals, individuals with multiple sexual partners, dialysis patients, iv drug users, and recipients of repeated transfusions. Health care workers accidentally exposed to materials infected with hep b (such as needle sticks), and individuals with known sexual contact with hep b patients are available in the u.s. Both are highly effective and provide protection even after only one dose. Two doses are recommended for adults and 3 doses for children (under 18 years of age) to provide prolonged protection. Vaccination, hepatitis b: hepatits b (hep b) vaccine gives prolonged protection, but 3 shots over a half year are usually required. In the u.s., all infants receive hep b vaccine. Two vaccines (engerix-b, and recombivax-hb) are available in the us. The first dose of hep b vaccine is frequently given while the newborn is in the hospital or at the first doctor visit following birth. The second dose is given about 30 days after the initial dose. A booster dose is performed approximately six months later. Babies born to mothers testing positive for hep b receive, in addition, hbig (hep b immune globulin) for prompt protection. Older children (11-12 years) are advised to receive a hep b booster as are adults in high-risk situations including healthcare workers, dentists, intimate and household contacts of patients with chronic hep b infection, male homosexuals, individuals with multiple sexual partners, dialysis patients, iv drug users, and recipients of repeated transfusions. Health care workers accidentally exposed to materials infected with hep b (such as needle sticks), and individuals with known sexual contact with hep b patients are usually given both hbig and vaccine to provide immediate and long term protection.
(12 Dec 1998)
vaccination, hib This vaccine is to prevent disease caused by the haemophilus influenzae type b (hib) bacteria. The h. Influenzae (h. Flu) bacteria can cause a range of serious diseases including meningitis with potential brain damage and epiglottitis with airway obstruction poisoning. The hib vaccine is usually given at 2, 4 and 6 months of age. A final booster is given at 12-15 months of age. Hib vaccine rarely causes severe reactions.
(12 Dec 1998)
vaccination, infectious hepatitis See Vaccination, hepatitis a.
(12 Dec 1998)
vaccination, measles See Vaccination, MMR. Vaccination, mmr: the standard vaccine given to prevent measles, mumps and rubella (german measles). The mmr vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination hould be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or mmr vaccination prior to entrance. Most children should receive mmr vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the mmr vaccine. Pregnant women should wait until after delivery before being immunised with mmr. People with HIV or aids should normally receive mmr vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination.
(12 Dec 1998)
vaccination, mumps See Vaccination, MMR. Vaccination, pneumococcal pneumonia: this vaccine, which prevents one of the most common and severe forms of pneumonia, is usually given only once in a lifetime, usually after the age of 55, to someone with ongoing lung problems (such as chronic obstructive pulmonary disease (copd) or asthma) or other chronic diseases (including those involving the heart and kidneys). This vaccination would rarely be given to children.
(12 Dec 1998)
vaccination, polio The vaccines available for vaccination against polio are opv (oral polio vaccine) and ipv (inactivated polio vaccine). Opv is still the preferred vaccine for most children. As its name suggests, it is given by mouth. Ipv, or inactivated polio vaccine is given as a shot in the arm or leg. Infants and children should be given four doses of opv. The doses are given at 2 months, 4 months, 6-18 months and 4-6 years of age. Persons allergic to eggs or the drugs neomycin or streptomycin should receive opv, not the injectable ipv. Conversely, ipv should be given if the vaccine recipient is on long-term steroid (cortisone) therapy, has cancer, or is on chemotherapy or if a household member has aids or there is an unimmunised adult in the house.
(12 Dec 1998)
vaccination, rubella See Vaccination, MMR.
(12 Dec 1998)
vaccination, varicella zoster See Vaccineation, chickenpox.
(12 Dec 1998)
vaccinator 1. A person who vaccinates.
Synonym: vaccinist.
2. A scarifier or other instrument used in vaccination.
(05 Mar 2000)
vaccine <pharmacology> A suspension of attenuated or killed microorganisms (bacteria, viruses or rickettsiae), administered for the prevention, amelioration or treatment of infectious diseases.
Origin: L. Vaccinus
(18 Nov 1997)
vaccine bodies Old term pertaining to intracellular body's that were erroneously thought to be forms in the life cycle of a protozoan organism, Cytorrhyctes vaccinae, postulated to be the causal agent of vaccinia.
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 2
  • Vaccines, Combined - »õâ Two or more vaccines in a single dosage form.
    Synonyms : Vaccines, Combination, Combination Vaccines, Combined Vaccines
  • Vaccines, Conjugate - »õâ Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognized by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection.
    Synonyms : Conjugate Vaccines
  • Vaccines, Contraceptive - »õâ Vaccines or candidate vaccines used to prevent conception.
    Synonyms : Antifertility Vaccines, Vaccines, Antifertility
  • Vaccines, DNA - »õâ Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers.
    Synonyms : DNA Vaccines, Naked, DNA Vaccines, Recombinant, Vaccines, Naked DNA, Vaccines, Nucleic Acid, Vaccines, Polynucleotide
  • Vaccines, Edible - »õâ Vaccines or candidate vaccines derived from edible plants. Transgenic plants (PLANTS, TRANSGENIC) are used as recombinant protein production systems and the edible plant tissue functions as an oral vaccine.
    Synonyms : Edible Vaccines
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 10 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 3 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¹Ù½ºÄÚݼ¿ - »õâ
¼­¿ïÁ¦¾à
A37001821 ATSO
ÀϹÝÀǾàǰ | ±Þ¿©
¹Ù½ºÅ¥¶óÆ®Á¤ - »õâ
Çѱ¹º£¸µ°ÅÀΰÖÇÏÀÓ
A07600181 Bamethan Sulfate
Àü¹®ÀǾàǰ | »èÁ¦
¹Ù¸Þ¼ÕÁöÅ©¸² - »õâ
Àϵ¿Á¦¾à
A03401571 Betamethasone valerate, Gentamicin Sulfate
Àü¹®ÀǾàǰ | »èÁ¦
¹Ù·Ñ¾× - »õâ
µ¿±¤Á¦¾à
A01303361 Betamethasone valerate
Àü¹®ÀǾàǰ | ±Þ¿©
¹Ù·ç¼¼ÆÄÁÖ1g - »õâ
½ÅdzÁ¦¾à
A00350261 Ceftizoxime Sodium
Àü¹®ÀǾàǰ | ±Þ¿©
¹Ù·ç¼¼ÆÄÁÖ0.5g - »õâ
½ÅdzÁ¦¾à
A00350251 Ceftizoxime Sodium
Àü¹®ÀǾàǰ | ±Þ¿©
¹Ù·Î·ÐÁ¤ - »õâ
±¹Á¦¾àǰ°ø¾÷
A03002431 Clonixin Lysinate
ÀϹÝÀǾàǰ | ±Þ¿©
¹Ù¸®¿òÁÖ10mg - »õâ
Çѱ¹·Î½´
G11400091 Diazepam
Àü¹®ÀǾàǰ | »èÁ¦
¹Ù·ùÁ¦ÆÊÁ¤2mg - »õâ
ȯÀÎÁ¦¾à
G01000171 Diazepam
Àü¹®ÀǾàǰ | »èÁ¦
¹Ù¸®¿òÁ¤2mg - »õâ
Çѱ¹·Î½´
G11400051 Diazepam
Àü¹®ÀǾàǰ | »èÁ¦
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 10 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
variable something that is likely to vary; something that is subject to variation; "the weather is one variable to be considered" liable to or capable of change; "rainfall in the tropics is notoriously variable"; "variable winds"; "variable expenses" a quantity that can assume any of a set of values variable star: a star that varies noticeably in brightness varying: marked by diversity or difference; "the varying angles of roof slope"; "nature is infinitely variable" a symbol (like x or y) that is used in mathematical or logical expressions to represent a variable quantity (used of a device) designed so that a property (as e.g. light) can be varied; "a variable capacitor"; "variable filters in front of the mercury xenon lights"
Ãâó: wordnet.princeton.edu/perl/webwn
valerian a plant of the genus Valeriana having lobed or dissected leaves and cymose white or ink flowers
Ãâó: wordnet.princeton.edu/perl/webwn
valeric acid a clear liquid carboxylic acid used in perfumes and drugs
Ãâó: wordnet.princeton.edu/perl/webwn
valid well grounded in logic or truth or having legal force; "a valid inference"; "a valid argument"; "a valid contract"; "a valid license" still legally acceptable; "the license is still valid"
Ãâó: wordnet.princeton.edu/perl/webwn
vascular of or relating to or having vessels that conduct and circulate fluids; "vascular constriction"; "a vascular bundle"
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vaccillant
    =VACILLATING
  • vaccinal
    ¹é½Å(¿ìµÎ)ÀÇ
  • vaccinate
    ¿¹¹æÁֻ縦 ³õ´Ù
  • vaccinate
    ¿ìµÎ¸¦ Á¢Á¾ÇÏ´Ù;¹é½Å ÁÖ»ç(¿¹¹æ Á¢Á¾) ÇÏ´Ù
  • vaccination
    ¿ÎÂð ÁÖ»ç
  • vaccination
    ¹é½Å(¿¹¹æ)Á¢Á¾;Á¾µÎ;Á¾µÎ ÀÚ±¹
  • vaccinator
    Á¾µÎ ÀÇ»ç;¿ìµÎÄ®;Á¢Á¾ ÁÖ»ç±â
  • vaccine
    ¿ìµÎÁ¾
  • vaccine
    ¿ìµÎÁ¾;¹é½Å
  • vaccinee
    ¹é½Å ÁÖ»ç(Á¾µÎ)¸¦ ¸ÂÀº »ç¶÷
  • vaccinia
    ¿ìµÎÁ¾;¹é½Å
  • vaccinization
    ¿¬¼Ó Á¾µÎ(¸é¿ªÀÌ µÉ ¶§±îÁöÀÇ)
  • vacillate
    Èçµé¸®´Ù
  • vacillate
    µ¿¿äÇÏ´Ù;(¸¶À½,»ý°¢ÀÌ)Èçµé¸®´Ù
  • vacillating
    µ¿¿äÇÏ´Â
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
VA the act of making something legally void
VA leisure time away from work
VA spend or take a vacation
VA a dwelling (a second home) where you live while you are on vacation
VA an area where many people go for recreation
VA someone on vacation
VA the act of taking a vacation
VA someone on vacation
VA cow-cockles
VA European annual with pale rose-colored flowers
VA European annual with pale rose-colored flowers
VA perfomr vaccinations or produce immunity in by inoculation
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 2
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á